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Edited by Hans-Dieter KlenkAbstract In this study, we have identiﬁed 876 polymorphism
sites in 145 complete or partial genomes of SARS-CoV
available in the NCBI GenBank. One hundred and seventy-
four of these sites existed in two or more SARS-CoV genome
sequences. According to the sequence polymorphism, all
SARS-CoVs can be divided into three groups: (I) group 1,
animal-origin viruses (such as SARS-CoV SZ1, SZ3, SZ13
and SZ16); (II) group 2, all viruses with clinical origin during
ﬁrst epidemic; and (III) group 3, SARS-CoV GD03T0013.
According to 10 special loci, group 2 again can be divided into
genotypes C and T, which can be further divided into sub-
genotypes C1–C4 and T1–T4. Positive Darwinian selections
were identiﬁed between any pair of these three groups.
Genotype C gives neutral selection. Genotype T, however,
shows negative selection. By comparing the death rates of
SARS patients in the diﬀerent regions, it was found that the
death rate caused by the viruses of the genotype C was lower
than that of the genotype T. SARS-CoVs might originate
from an unknown ancestor.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Severe acute respiratory syndrome; SARS-CoV;
Genotype; Phylogeny; Most recent common ancestor1. Introduction
In 2002, a new infectious disease was found in the south-
ern part of China which had high mortality and morbidity
and was termed ‘‘severe acute respiratory syndrome’’
(SARS). It aﬀected 8096 people and led 774 patients to
death around the world, within a very short span of time
[1]. Several studies have shown that SARS is caused by a
new member of the coronavirus family. The SARS corona-
virus (SARS-CoV) was supposed to be transmitted from
wild animals [2–4]. This hypothesis was then supported by
the identiﬁcation of a SARS-CoV-like virus in civet cats,*Corresponding authors. Fax: +86 571 87235111 (Z.-G. Wang), +86
577 88892766 (Q.-Y. Bao).
E-mail addresses: wzg188@sina.com.cn (Z.-G. Wang),
baoqy@genomics.org.cn (Q.-Y. Bao).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.07.075sold in markets in south China. This isolate had more than
99% sequence identity with SARS-CoV, indicating that the
virus was recently transferred from animals to human beings
[5]. However, according to a recent report there is no direct
evidence that the civet cat virus is the origin of the SARS-
CoV [6]. Although unlikely, the possibility that SARS-CoV
positive animals were infected from humans cannot be for-
mally excluded, and it was indeed reported that SARS-
CoV was transmitted from man to pig [7]. The mechanism
how the pathogen broke the barrier between its natural res-
ervoir and man is still unclear [8].
After the ﬁrst SARS epidemic, there were three incidences
of laboratory infections in Singapore, Taiwan and Beijing
[9–11]. Furthermore, in Guangdong, China, SARS patients
were observed to suﬀer from ‘‘mild clinical symptoms’’
[12]. It is therefore important to further explore the charac-
teristics of the SARS-CoV genome and trace the source of
the epidemic.
There were several studies on SARS-CoV phylogeny and
genotyping published immediately after SARS was identiﬁed.
According to 4 polymorphism sites, Ruan et al. [13] ﬁrst
genotyped 14 previously published SARS-CoV genomes at
the beginning of May, 2003. Subsequently, Li et al. [14] pro-
posed genotypes of C and T in 17 SARS-CoV genomes
based on 5 polymorphism sites. Regional and international
transmission types were also proposed [15,16]. SARS-CoV
Su-10 and CUHK-W1 were genotyped into two diﬀerent
groups even though they were all isolated in Hongkong
[17]. Based on the 7 loci of 44 SARS-CoV genomes, C
and T genotypes were further modiﬁed and named as the
Yexin and Xiaohong genotypes [18]. According to 5 poly-
morphism sites, 63 SARS-CoV genomes were divided into
early, middle and late phase genotype groups [19]. The poly-
morphism sites analyzed in these papers were almost the
same.
Three successful examples have been reported where infec-
tion chains have been traced by comparing variations in
SARS-CoV genomes. The ﬁrst SARS-CoV laboratory infec-
tion incidence was conﬁrmed by identifying 13 variant loci in
the SARS-CoV genomes [9]. Secondly, it was found that the
SARS-CoV isolated from the patient with ‘‘mild clinical symp-
toms’’ and the SARS-CoV (or SARS-CoV-like virus) isolated
from animals resembled each other in the sequence encoding
the spike protein [19]. This study indicates that virus-carryingblished by Elsevier B.V. All rights reserved.
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analysis conﬁrmed the laboratory infection of a technician
who was working with SARS-CoV [20].
Up to date, there are already 295 complete or partial
SARS-CoV genome sequences available in GenBank. A
new method of genotyping is proposed in this study. The
results show that all SARS-CoV genomes are clustered into
three groups and that SARS-CoV genomes in the second
group belong to genotypes C and T. These two genotypes
can be further divided into 8 sub-genotypes. In this study
we also analyzed the SARS death rate, SARS-CoV origin,
and population genetics.2. Materials and methods
2.1. SARS-CoV genome data
SARS-CoV ZJ01 (Accession No. AY297028) was isolated in Zhe-
jiang province, China [14]. Other SARS-CoV genome sequences were
downloaded from NCBI GenBank database. Two hundred and
ninety-ﬁve complete or partial SARS-CoV genomes were searched.
After removing shorter and repeated records, 101 complete genomes
and 44 partial genome sequences were collected for ﬁnal analysis (by
September 20, 2004). The detailed information of sequences of the ear-
liest 20 records in GenBank is shown in Table 1 and the other se-
quences are listed in Table S1 (Supplementary materials). The newest
information about domestic and international SARS fatality rates
were downloaded from Health Ministry of China (http://
168.160.224.167/) and WHO websites (http://www.who.int/csr/sars/
country/Table2004_04_21/en/).2.2. Analysis platform tools and methods
The analysis platform was PC server based on P4 ultra thread
technological CPU and the operating system was Windows XP. Clu-
stalW version 1.83 was used for multiple sequence alignments. Tree-
View (Win32) version 1.6.6 and MEGA 2.0 were used to draw
phylogenetic tree. DNASP 4.0 was used to analyze single nucleosideTable 1
The earliest 20 SARS-CoV genomes available in GenBank
Isolate Accession No. Length of
sequence (bp)
Date of
submission
Tor2 AY274119.3 29751 13-4-2003
BJ01 AY278488.2 29725 17-4-2003
BJ02 AY278487.3 29745 17-4-2003
BJ03 AY278490.3 29740 17-4-2003
Urbani AY278741.1 29727 17-4-2003
HKU-398849 AY278491.2 29742 17-4-2003
CUHK-W1 AY278554.2 29736 17-4-2003
GD01 AY278489.2 29757 17-4-2003
BJ04 AY279354.2 29732 19-4-2003
CUHK-Su10 AY282752.1 29736 24-4-2003
Sin2500 AY283794.1 29711 27-4-2003
Sin2677 AY283795.1 29705 27-4-2003
Sin2679 AY283796.1 29711 27-4-2003
Sin2748 AY283797.1 29706 27-4-2003
Sin2774 AY283798.1 29711 27-4-2003
TW1 AY291451.1 29729 6-5-2003
Frankfurt1 AY291315.1 29727 6-5-2003
ZJ01 AY297028.1 29715 12-5-2003
TWC AY321118.1 29725 11-6-2003
HSR 1 AY323977.2 29751 16-6-2003
aPartial sequence at the date of ﬁrst release. BJ01 genome became complete
2003.
bDate of ﬁrst release not available.polymorphism. The SARS-CoV sequences were arrayed with Clu-
stalW program, and alignment was further manually examined
and adjusted. Only those variant sequence loci that were present
in at least two independent sequences were selected for further anal-
yses [13,18,19]. Deletion and insertion in SARS-CoV genomes and
the neutral mutation in the spike protein gene, etc., were also esti-
mated. The latest version (NC_004718) of the ﬁrst submitted
SARS-CoV genome sequence (SARS-CoV TOR2, AY274119) was
used as the control reference.3. Results
3.1. The distribution of single nucleotide polymorphism loci of
SARS-CoV genome
Eight hundred and seventy-six mutation loci were identiﬁed
among the 145 complete or partial SARS-CoV genomes (the
over all mutation rate was 2.94%, 876/29751), of which 174
loci were identiﬁed in more than two genome sequences. To
avoid errors that might be introduced by sequencing and cell
culture passages, only the latter group of 174 loci was ana-
lyzed. Diﬀerent characteristics of the polymorphism sites were
found. The loci related to T mutation accounted for 60.9%
(106/174), and C, A and G mutation loci accounted for
39.6% (69/174), 39.0% (68/174) and 27.0% (47/174), respec-
tively. It was obvious that T mutation had the priority. Most
of the loci, except for 7 sites, were limited to one pair of nucle-
otide variations. One hundred and twenty loci were transition
mutations (78 CT, 42 AG), and 48 loci were transversion
mutations. The ratio of transition mutations to transversion
mutations was 2.5 (120/48), and 6 loci were of deletion
mutation.
3.2. The distribution of deleted regions in SARS-CoV genome
The sequence deletion in SARS-CoV genome mainly oc-
curred in the regions between sars7a to N protein by losingDate of ﬁrst
release
Institute of submission
14-4-2003 BCCA Genome Sciences Centre, Canada
21-4-2003a Academy of Military Medical Sciences, China
21-4-2003a Academy of Military Medical Sciences, China
21-4-2003a Academy of Military Medical Sciences, China
21-4-2003 CDC, Atlanta, USA
18-4-2003 University of Hong Kong
18-4-2003 Chinese University of Hong Kong
21-4-2003a Academy of Military Medical Sciences, China
23-4-2003a Academy of Military Medical Sciences, China
7-5-2003 Chinese University of Hong Kong
9-5-2003 Genome Institute of Singapore
9-5-2003 Genome Institute of Singapore
9-5-2003 Genome Institute of Singapore
9-5-2003 Genome Institute of Singapore
9-5-2003 Genome Institute of Singapore
14-5-2003 Taiwan University
16-3-2004b University of Wuerzburg, Germany
19-5-2003 Zhejiang CDC, China
26-6-2003 Taiwan CDC, China
24-6-2003 Scientiﬁc Research Institute, Italy
in May, 2003. BJ02, BJ03, BJ04 and GZ01 became complete in June,
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4930 Z.-G. Wang et al. / FEBS Letters 579 (2005) 4928–493612, 29, 30, 31, 32, 39, 49, 57, 82, 137 or 415 nt, mostly losing a
29 nt fragment in sars8b (Table 2).
3.3. SARS-CoV genotype and sub-genotype
Key mutation loci are shown in Table 3 (identiﬁed by
using nucleotide–nucleotide BLAST program at NEBI and
Clustalw 1.83), and the phylogenetic tree of 174 loci
(Fig. 1) showed that, according to the polymorphism sites
of C9404T, C9479T, G17564T, G19838A, A21721G,
C22222T, G22517A, G23823T, T27243C and C27827T, the
SARS-CoV genomes of the ﬁrst epidemic can be divided
into two genotypes, genotype C and T. The characteristic
of the genotype C was that the genomes had at least one po-
sition with the same nucleotide as 10 loci listed above
(C:C:G:G:A:C:G:G:T:C). These genomes included GD01,
ZS-C, CUHK-W1, BJ01, BJ302-1 and GZ-C, etc. The char-
acteristic of the genotype T was that the genomes must have
all the 10 nucleotides of T:T:T:A:G:T:A:T:C:T. This
genotype included GZ-B, ZJ01, Sin2679, Urbani, TC1,
CUHK-AG01, Sino1-11, TOR2 and AS, etc. These poly-
morphism sites were located in 5 diﬀerent regions of the
replicase 1A, 1B, spike protein gene, sars6 and sars8a.
Except the 4th and the 7th loci that were synonymous muta-
tions, the others were non-synonymous mutations with ami-
no acid changes of A/V, A/V, E/D, G/D, T/I, D/Y, P/L and
R/C, respectively. It revealed the strongly biased characteris-
tic of changes in genotypes associated with changes in
phenotypes. Genotype C can be further divided into 4
sub-genotypes. Sub-genotype C1 had, besides the 10 sites
mentioned above (Table 3), C3626T, C8559T, T22207C
and G22522A loci that would distinguish them from the
others. In the same way, sub-genotype C2 had G3962A,
G9448T and T19882C and sub-genotype C4 had T9854C
site. As shown in Fig. 1, the sub-genotype C3 is a transi-
tional one. Genotype T could also be divided into 4 sub-
genotypes, sub-genotype T1, T2, T3 and T4. Besides the
10 common polymorphism sites shown above, they had 3,
4, 4 and 3 variant loci, respectively (Table 3). ZJ01, HSR1
and Sin2679, belonging to genotype T and with more poly-
morphism sites identiﬁed in their genomes, located in the
midst of the phylogenetic tree (Fig. 1) and were not sub-gen-
otyped in this paper (Table 3). Only some genomes in both
sub-types C1 and C2 had the 29 nt fragments. SARS-CoV
genomes in sub-type T3 lacked a region of 415 nt (Fig. 1,
Table 2).3.4. Spike protein gene and complete genome phylogeny analysis
To verify the genotyping results of the 174 loci shown
above, we reconstructed the phylogenetic trees of 122 spike
protein genes and 101 complete genomes (Fig. 2A and B).
As can be seen in Fig. 2A, most SARS-CoV were clustered
in accordance with their genotypes. Some partial genome
sequences were situated in this tree, such as CUHK-L2,
SZ1, GZ43, HSZ-A, GD03T0013, BJ302-1, HKU-65806
and LY, could not be properly located in the phylogenetic
tree based on 174 loci. The genomes of GZ-C and QXC1
showed intercrossing features between genotype C and T.
Some sub-genotypes, such as C1, C2, T2 and T3, were easily
recognized in the spike protein gene tree, but some sub-
genotypes were intercrossed. In the phylogenetic tree of
complete genomes, the clusters of genotype C and T and 8
Table 3
The distribution characteristics of the key mutation loci of SARS-CoV genomes
N, not detected locus; , deletion locus; red broken line, C/T genotype separate line; orange broken line, sub-genotype separate line; genome loci, SARS-CoV model virus NC_004718 as reference.
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Fig. 1. Neighbor-joining tree for the 174 mutation sites of SARS-CoV
genomes. The tree was reconstructed based on the 174 variant sites
among the genomes. Bootstrap = 1000. The length indicated number
of variant sites. s: genomes with 29 nt insert. n: genomes with 415 nt
deletion. C: genotype C; C1–C4: sub-genotype C1–C4; T: genotype T;
T1–T4: sub-genotype T1–T4.
4932 Z.-G. Wang et al. / FEBS Letters 579 (2005) 4928–4936sub-types are obvious (Fig. 2B). One of the reasons for this
might be that the spike protein genes were less informative
than the complete genomes.3.5. The evolutionary relationship among GD03T0013, the
animal source viruses and the ﬁrst epidemic SARS-CoVs
Fig. 3 shows that the genetic distance of recent SARS-
CoV genome of GD03T0013 was closer to the ﬁrst epidemicSARS-CoV GZ02 than to the animal-origin SARS-CoV
SZ3.3.6. Polymorphism and diversity analysis of the spike gene
among the genotypes and the groups
The genetic characteristics of the genotypes were further
analyzed based on the sequence polymorphism of the spike
protein genes (Table 4). The Pa/Ps value was 1.047 for the
polymorphism sites among the genomes of genotype C that
showed neutrality or ﬁne selection. In genotype T, non-
synonymous mutation loci decreased, and the Pa/Ps value
was 0.230 (P < 0.05, with signiﬁcant diﬀerences between the
genomes), which showed negative selection in this genotype.
The Ps% value of synonymous mutation, which was less
inﬂuenced by the general environment selection, had no
signiﬁcance between the two genotypes. The Ps% value was
one of the characteristic indices identifying the genetic rela-
tionship of the populations, and the Ps% value of group 2
(C + T) was approximately half of that of the group 1
(animal source viruses, Table 4). The animal source viruses
(SARS-CoV SZ1, SZ3, SZ13 and SZ16) also showed negative
selection among themselves.
According to the phylogenetic trees based on the diﬀerent
data sets described above, the genetic diversities between any
pair of 3 groups (the animal source viruses, the ﬁrst
epidemic viruses including C and T genotypes, and
GD03T0013) were evaluated. The Ka/Ks values of each
two groups were all greater than 1, showing positive Dar-
winian selections between these groups. On the other hand,
the Ka/Ks values between genotype C and ZS-B (one of the
ﬁrst epidemic viruses and the closest to the animal origin
viruses) or between genotype T and ZS-B were all less than
1 (Figs. 1 and 2A, Table 4).
All analyses described above indicated that the animal
source virus and GD03T0013 virus could be classiﬁed as two
relatively independent populations. 145 SARS-CoV genome
sequences could be classiﬁed into three groups, and the group
2 could further be divided into two genotypes and eight sub-
genotypes (Fig. 4).3.7. Estimated timing of SARS-CoV origin
Based on the new concept of dividing all the 145 SARS-
CoV genome sequences into three groups, the origin of group
2 and group 3 (assuming group 1 as outer source group) was
estimated. Eight candidates including four animal origin gen-
omes of group 1 identiﬁed in April to May, 2003, three early
genomes of HGZ8L1-A, ZS-B and GZ02 in sub-genotype C1
of group 2 in January to February, 2003, and the genome of
GD03T0013 of group 3 in December, 2003, were selected to
analyze the date when their most recent common ancestor
was existed. Based on analysis of the diversities of spike pro-
tein genes, the synonymous mutation rate Ks between group 1
and 2 was 0.00321 ± 0.00135, and the synonymous mutation
rate Ks between group 1 and 3 was 0.00509 ± 0.00199.
Assuming that the synonymous mutation rate was constant,
a linear regression analysis was evaluated. The linear equa-
tion of Ks and occurrence time T is Ks = 0.000171T +
0.00321 (from January, 2003, with one month intervals),
and the date for the most recent common ancestor was esti-
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Fig. 2. Neighbor-joining trees of spike gene and complete SARS-CoV genomes. The trees were constructed using the Kimura 2-parameter.
Bootstrap = 1000. s: with 29 nt segments. r: T genotype. (A) The tree of 122 spike genes of SARS-CoV. The length indicated number of nucleotide
diﬀerence per site of spike gene. (B) The topological tree of 101 complete genomes of SARS-CoV.
Fig. 3. Neighbor-joining trees of newlyoccurred, animal-origin andﬁrst
epidemic SARS-CoVs. (A)The treewas constructedusing theKimura 2-
parameter of nucleotide diﬀerence. Bootstrap = 1000. The length
indicated number of nucleotide diﬀerence per site of the spike gene.
The number of cluster point indicated bootstrap replication percent. The
genetic distance of the newly occurredGD03T0013was closer to the ﬁrst
epidemicGZ02 than the animal-origin SZ3. (B)The treewas constructed
using the p-distance of nucleotide diﬀerence. Bootstrap = 1000. The
number of cluster point indicated bootstrap replication percent. The
FIPV-X06170 (feline infectious peritonitis virus) was used as an out-
groupwithin the spike gene data set. A bootscan recombination analysis
of the spike gene revealed high nucleotide identity between the SARS
virus and a feline infectious peritonitis virus throughout the gene [21].
Z.-G. Wang et al. / FEBS Letters 579 (2005) 4928–4936 4933mated to lie in May 2002 (range between early March, 2002
and late July, 2002).3.8. Relation between genotypes and SARS fatality rate
Information about SARS fatality rate and genotypes from
all regions are shown in Table 5. Comparing SARS fatality
rates of diﬀerent regions, it was found that SARS-CoV gen-
omes of genotype T had the highest case fatality rate.4. Discussion
Several studies on SARS-CoV genome genotyping and
grouping have been published [13–19]. Some presented the
regional and international transmission types according to
the epidemic regions and some divided the viruses into early,
middle, and late phase groups according to the time of the
SARS epidemic in a certain region (Guangdong of China).
Based on genome characteristics of 145 SARS-CoVs, a
new concept of three groups, two genotypes and eight sub-
types was established. The genotype C of group 2 in this
work was almost compatible with the regional transmission
type and the early, middle phase groups, while genotype T
of group 2 was compatible with the international transmis-
sion type and the late phase group as well [16,19]. One of
the advantages of the new classiﬁcation is that it ﬁts global
and regional epidemic feature analysis, such as for SARS-
CoVs in Taiwan and Singapore. Up to date, all the genomes
from clinical samples in the early, middle, and late phase of
the SARS epidemic in these regions belonged to genotype T.
The concept of dividing all SARS-CoVs into three groups
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4934 Z.-G. Wang et al. / FEBS Letters 579 (2005) 4928–4936was mainly based on the phylogenetic analysis and the posi-
tive Darwinian selection. Because of the limited virus num-
ber in group 1 and 3, this grouping has to be further
conﬁrmed.
The source of SARS-CoVs was traced. It was clear that
genotype T was derived from genotype C [14,18,19]. The ori-
gins of each sub-genotype were also elucidated [22–24] and
are consistent with our results. But the origin of the SARS-
CoV remains a question and needs further investigation.
Zhao et al. [25] analyzed 16 SARS-CoV genomes and pro-
posed that the closest common ancestor might have existed
during the spring of 2002 which is consistent with the date,
May 2002, estimated by the spike gene synonymous mutation
rate of the three groups in this work. It is very probable that
the three groups originated from an unknown common
ancestor.
The genotype classiﬁcation of SARS-CoV plays an impor-
tant role in tracing and controlling SARS prevalence.
According to genome sequence variation analysis, genotype
shifts of SARS-CoVs in the main epidemic regions during
the ﬁrst epidemic were obvious. The sub-genotypes C1 and
C2, that have a closer relationship to the virus of animal ori-
gin, ﬁrst appeared in Guangdong, and then appeared the
sub-genotype C3. The dominant viruses in HongKong were
of genotype T, but genotype C also appeared there. Simi-
larly, although sub-genotype C4 dominated in Beijing, geno-
type T also existed there. In Singapore, they had all the
genomes of genotypes T, mostly of sub-genotypes T1 and
T2. The viruses in Taiwan were all of genotype T, mostly
of sub-genotype T4. With more SARS-CoV genome se-
quences and more complete epidemiological data released,
the characteristics of the SARS-CoVs variations in the geno-
types, as well as the features about the epidemic phases, the
epidemic regions, the clinical symptoms, and the viruses
adaptation to the human host, will become clearer and
clearer.
The genotype was apparently correlated with virulence of
the SARS-CoV. SARS-CoV GD03T0013 was from the
patient with ‘‘mild clinical symptoms’’, and its genome
sequence was similar to that of the sub-genotype C1. Exper-
iments have also demonstrated that SARS-CoVs of the
genotype T had a stronger ability to cause cyto-pathogenic
eﬀects (CPE) than those of the genotype C. The CPE of
the genotype T remained stable during passages in cell
cultures [26]. In the ﬁrst epidemic, SARS patients in
Guangzhou seldom suﬀered from diarrhea, and the SARS-
CoV genomes were mainly of the genotype C [27]. The
majority of SARS patients in Hongkong, however, suﬀered
from diarrhea and it turned out that SARS-CoVs of the
genotype T dominated [28]. SARS-CoVs of diﬀerent
genotypes might have diﬀerent virulence. Moreover, the
serum from mice immunized with inactivated SARS-CoV
BJ01 of genotype C is able to neutralize the invasiveness
of SARS-CoV BJ01 itself into Vero cells [29]. Further
investigations are required to demonstrate whether this
serum could prevent the cells from the invasiveness of the
SARS-CoV PUMC01 or others of the genotype T.
If, in the future, a SARS-CoV epidemic appears again,
after rounds of random mutations, it might cause slight clin-
ical symptoms at the initial stage of the infection. Through
positive Darwinian selection, a virus with greater virulence
might cause more severe clinical symptoms. A period of neu-
 SARS coronavirus 
Group 1 Group 2  Group 3 
 Genotype C  Genotype T
SZ1 
SZ3 
SZ13 
SZ16 
GD03T0013
C1 C2 C3 C4 T1 T2 T3 T4
HGZ8L1-A HSZ-Bc GZ50 BJ01 Sin2500 Sin852 LC2 TWJ
ZS-A HSZ-Cb HZS2-A BJ02 Sin2774 Sin845 LC3 TW8
GD01 etc. HZS2-E NS-1 SinP1 Sin3765v LC4 GD69
etc. HZS2-F LLJ-2004 Frankurt1 etc. LC5 AG01
etc. etc. etc. etc.
Fig. 4. Distribution of SARS-CoVs in three groups, two genotypes and eight sub-genotypes.
Table 5
Comparison of the case fatality rates and genotypes of SARS-CoV in diﬀerent regions
Region Cumulative number of case Number of death Case fatality ratio (%) C genotype T genotype
Mainland China 5327 349 7 42 11
Beijing 2521 193 8 14 5
Guangdong 1512 58 4 26 3
Shanghai 8 2 25 2 1
Zhejiang 4 1 25 0 1
Hubei 7 1 14 0 1
Hong Kong 1755 299 17 3 12
Singapore 238 33 14 0 24
Taiwan 346 37 11 0 22
Canada 251 43 17 0 1
Germany 9 0 0 0 2
Italy 4 0 0 0 2
Russian 1 0 0 0 1
Thailand 9 2 22 0 1
Other 156 11 7 0 0
Total 8096 774 10 45 76
Z.-G. Wang et al. / FEBS Letters 579 (2005) 4928–4936 4935trality selection and negative selection might follow, and dif-
ferent symptoms and case fatality rates might appear. On
the other hand, diﬀerent epidemic features might occur if
there are stable intermediate hosts for SARS-CoVs of the
group 2 (such as SARS-CoV of genotype T) after the ﬁrst
epidemic, and these viruses might cause epidemics in man
again.
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